Close Menu

NEW YORK – A company associated with an investment fund that acquired patents initially awarded to disgraced testing firm Theranos is suing BioMérieux subsidiary BioFire Diagnostics, alleging its coronavirus tests infringe the patents.

In a complaint filed March 9 in the US District Court for the District of Delaware, Labrador Diagnostics said BioFire's FilmArray products infringe US Patent numbers 8,238,155 and 10,533,994, which cover fluidic systems used in diagnostics.

Both patents were assigned to Theranos and its founder Elizabeth Holmes as an inventor.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.